scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...987137W |
P356 | DOI | 10.1371/JOURNAL.PONE.0087137 |
P932 | PMC publication ID | 3909066 |
P698 | PubMed publication ID | 24498028 |
P5875 | ResearchGate publication ID | 260108868 |
P2093 | author name string | Chris K C Wong | |
Hin T Wan | |||
Yin G Zhao | |||
Pik Y Leung | |||
P2860 | cites work | Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000 | Q24680576 |
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
Selection of the appropriate method for the assessment of insulin resistance | Q27001024 | ||
Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review | Q28258639 | ||
The paradox of progress: environmental disruption of metabolism and the diabetes epidemic | Q28389669 | ||
Perinatal exposure to bisphenol-a and the development of metabolic syndrome in CD-1 mice. | Q33874480 | ||
Endocrine disruptors: from endocrine to metabolic disruption | Q34024583 | ||
Obesity, the Metabolic Syndrome, and Type 2 Diabetes in Developing Countries: Role of Dietary Fats and Oils | Q34136612 | ||
Endocrine disruptors in the etiology of type 2 diabetes mellitus. | Q34176083 | ||
Sex is a major determinant of CYP3A4 expression in human liver | Q34265530 | ||
Perfluoroalkyl acids: a review of monitoring and toxicological findings | Q34630884 | ||
How important are gender differences in pharmacokinetics? | Q34660699 | ||
Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers | Q34680365 | ||
Obesity, diabetes mellitus, and liver fibrosis | Q34979922 | ||
Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer | Q35579871 | ||
Gender-specific induction of cytochrome P450s in nonylphenol-treated FVB/NJ mice | Q35970874 | ||
Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes | Q36029231 | ||
Nutrition can modulate the toxicity of environmental pollutants: implications in risk assessment and human health. | Q36064775 | ||
Focus on prolactin as a metabolic hormone. | Q36413921 | ||
Ecotoxicological evaluation of perfluorooctanesulfonate (PFOS). | Q36469189 | ||
Involvement of insulin-like growth factor-I in the control of glucose homeostasis | Q36618420 | ||
Emerging endocrine disrupters: perfluoroalkylated substances | Q37100285 | ||
Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults | Q37139485 | ||
Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance | Q37269509 | ||
Neonatal-maternal factors and perfluoroalkyl substances in cord blood. | Q50853255 | ||
Developmental exposure to di(2-ethylhexyl) phthalate impairs endocrine pancreas and leads to long-term adverse effects on glucose homeostasis in the rat. | Q51372050 | ||
Evaluation of placental and lactational pharmacokinetics of PFOA and PFOS in the pregnant, lactating, fetal and neonatal rat using a physiologically based pharmacokinetic model. | Q51421719 | ||
Sex-dependent regulation of hepatic cytochrome P-450 by DDT. | Q52538614 | ||
Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. | Q53586587 | ||
PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport. | Q54315844 | ||
Sex is a major determinant of CYP3A4 expression in human liver | Q56453603 | ||
Toxicogenomic Study of Triazole Fungicides and Perfluoroalkyl Acids in Rat Livers Predicts Toxicity and Categorizes Chemicals Based on Mechanisms of Toxicity | Q57555731 | ||
Trans-Placental Transfer of Thirteen Perfluorinated Compounds and Relations with Fetal Thyroid Hormones | Q58765976 | ||
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes | Q80178930 | ||
Effect of dietary fat on oral bioavailability of tepoxalin in dogs | Q81844124 | ||
Improved selectivity for the analysis of maternal serum and cord serum for polyfluoroalkyl chemicals | Q82486634 | ||
Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China | Q83829339 | ||
Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet | Q84131647 | ||
Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys | Q84884523 | ||
Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic | Q37853813 | ||
Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver | Q38034704 | ||
Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. | Q38072021 | ||
Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC) | Q39233321 | ||
Levels of 12 perfluorinated chemicals in pooled australian serum, collected 2002-2003, in relation to age, gender, and region | Q39761709 | ||
Structure-activity relationships and human relevance for perfluoroalkyl acid-induced transcriptional activation of peroxisome proliferation in liver cell cultures | Q39858220 | ||
Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid | Q42801273 | ||
Determination of energies and sites of binding of PFOA and PFOS to human serum albumin. | Q42844971 | ||
Dietary intake estimate for perfluorooctanesulphonic acid (PFOS) and other perfluorocompounds (PFCs) in UK retail foods following determination using standard addition LC-MS/MS. | Q43144402 | ||
Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system | Q43238768 | ||
Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid | Q43679963 | ||
Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland | Q43822053 | ||
Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys | Q44035477 | ||
Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals | Q44384066 | ||
Comparison on gestation and lactation exposure of perfluorinated compounds for newborns | Q44413711 | ||
Risk assessment for human consumption of perfluorinated compound-contaminated freshwater and marine fish from Hong Kong and Xiamen | Q44761825 | ||
Blood plasma concentrations of endocrine disrupting chemicals in Hong Kong populations | Q46183320 | ||
Perfluorooctane sulfonate-induced changes in fetal rat liver gene expression | Q46436503 | ||
Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis | Q46460012 | ||
Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA). | Q46750192 | ||
Lipid homeostasis and oxidative stress in the liver of male rats exposed to perfluorododecanoic acid | Q46889241 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e87137 | |
P577 | publication date | 2014-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Perinatal exposure to perfluorooctane sulfonate affects glucose metabolism in adult offspring | |
P478 | volume | 9 |
Q58566708 | Dietary Exposure to the Environmental Chemical, PFOS on the Diversity of Gut Microbiota, Associated With the Development of Metabolic Syndrome |
Q28383132 | EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals |
Q38799058 | Embryonic exposures to perfluorooctanesulfonic acid (PFOS) disrupt pancreatic organogenesis in the zebrafish, Danio rerio |
Q64946920 | Endocrine-disrupting chemicals and risk of diabetes: an evidence-based review. |
Q39400487 | Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature |
Q36710350 | Metabolic disruption in context: Clinical avenues for synergistic perturbations in energy homeostasis by endocrine disrupting chemicals |
Q29248099 | Metabolism Disrupting Chemicals and Metabolic Disorders |
Q64945556 | Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis. |
Q63255349 | Perfluorobutanesulfonic Acid Disrupts Pancreatic Organogenesis and Regulation of Lipid Metabolism in the Zebrafish, Danio rerio |
Q33683116 | Perfluorooctanesulfonate (PFOS)-induced Sertoli cell injury through a disruption of F-actin and microtubule organization is mediated by Akt1/2 |
Q50041783 | Perfluorooctanoic acid impaired glucose homeostasis through affecting adipose AKT pathway |
Q51246138 | Plasma Concentrations of Perfluoroalkyl Substances and Risk of Type 2 Diabetes: A Prospective Investigation among U.S. Women. |
Q38692106 | Polluted Pathways: Mechanisms of Metabolic Disruption by Endocrine Disrupting Chemicals |
Q62086877 | Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food |
Search more.